News from Merrimack Pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 13, 2017, 07:30 ET Merrimack Commences Tender Offer for Any and All of its Outstanding 4.50% Convertible Senior Notes Due 2020

Merrimack Pharmaceuticals (NASDAQ: MACK) (the "Company" or "Merrimack") today announced that it has commenced a tender offer (the "Tender Offer")...


Oct 10, 2017, 16:24 ET Merrimack Announces Settlement of Convertible Note Litigation

Merrimack Pharmaceuticals (NASDAQ: MACK) today announced that it has reached a settlement agreement with Wolverine Flagship Fund Trading Limited,...


Aug 31, 2017, 08:00 ET Merrimack Announces Date of One-for-Ten Reverse Stock Split

Merrimack Pharmaceuticals (NASDAQ: MACK) today announced that the previously disclosed one-for-ten reverse stock split of its issued and...


Aug 14, 2017, 06:55 ET Merrimack Augments Executive Team with Appointment of Jean Franchi as Chief Financial Officer

Merrimack Pharmaceuticals (NASDAQ: MACK) today announced that it has strengthened its executive management team with the appointment of Jean M....


Jul 24, 2017, 06:55 ET Merrimack Appoints Thomas Needham as Chief Business Officer

Merrimack Pharmaceuticals (NASDAQ: MACK) today announced further expansion of its executive management team with the appointment of Thomas E....


Nov 08, 2010, 15:00 ET Merrimack Pharmaceuticals Awarded $2.44 Million in Grants Under the Patient Protection and Affordable Care Program

Merrimack Pharmaceuticals was awarded $2.44 million to support research on 10 of its cancer programs through the Qualifying Therapeutic Discovery...


Jun 01, 2010, 16:51 ET Merrimack Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference

Merrimack Pharmaceuticals today announced that it will present at the Jefferies 2010 Global Life Sciences Conference in New York City. Robert...